Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1103886

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Acute intracerebral haemorrhage (ICH) is a serious form of stroke. Survivors of ICH are at high risk of repeat events. Blood pressure lowering is a very important to prevent repeat events but data shows blood pressure is poorly controlled in these patients. In this research we investigate whether an approach that uses a 'triple pill' strategy (3 low dose BP drugs in one pill) in ICH patients with mild to moderate hypertension can decrease major cardiovascular events.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2021

Funding Scheme: Project Grants

Funding Amount: $5,256,292.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

blood pressure | clinical trial | prevention | recurrent | stroke

Related Links